Two new nitrogen-containing compounds, pseudosteheterins A (1) and B (2), were isolated from the glycosides-enriched cardioprotective fraction of the 70% EtOH extract of the roots of Pseudostellaria heterophylla. Their structures were elucidated by spectroscopic methods, and the absolute configuration of 1 was established by quantum chemical TDDFT calculation of the ECD spectrum of its model compound. Pseudosteheterin B showed significant protective effects in H9c2 myocardial cells against CoCl 2 -induced injury. (Figure 1 ), were isolated through various column chromatographic techniques and their structures were identified by spectroscopic and computational methods. Cardioprotective effect evaluation showed that pseudosteheterin B showed significant protective effects in H9c2 myocardial cells against CoCl 2 -induced injury. Here, the isolation and structural elucidation of compounds 1 and 2, together with their myocardial protection are described.
Pseudostellaria heterophylla (Miq.) Pax is one of the most popular traditional Chinese medicines which possessed the function of promoting production of body fluid and nourishing lung and spleen [1] [2] [3] . Previous chemical studies resulted in the discovery of various bioactive components including cyclic peptides [4] , saponins [5] , volatile compounds [6] and fatty acids as well as a variety of other types of compounds. The polysaccharides-and glycosides-enriched fractions obtained from the extract of P. heterophylla showed cardioprotective effect on H9c2 myocardial cells against CoCl 2 -induced injury [7] . During our chemical investigation of the glycosides-enriched cardioprotective fraction, two new nitrogencontaining compounds, namely pseudosteheterins A (1) and B (2) (Figure 1 ), were isolated through various column chromatographic techniques and their structures were identified by spectroscopic and computational methods. Cardioprotective effect evaluation showed that pseudosteheterin B showed significant protective effects in H9c2 myocardial cells against CoCl 2 -induced injury. Here, the isolation and structural elucidation of compounds 1 and 2, together with their myocardial protection are described. 1.86 (br s), and 6.23 (br q, J = 7.2 Hz) as well as 13 C-NMR signals of δ C 172.7, 142.5, 129.6, 22.3, 18.0 were readily assigned to an angeloyl group [8] , while the remaining NMR data exhibited a resemblance to those of oxypinnatanine [9] , namely N 5 -(2,5-dihydro-2-furyl-3-hydroxymethyl)-γ-hydroxyglutamine. The distinct downfield shift of H 2 -6 (δ H from 4.26 and 4.18 in oxypinnatanine to 4.88 and 4.82 in 1) suggested that the angeloyl group was located at C 6 key HMBC correlation of H-6/C-1″ (δ C 172.7) and the α-hydroxy-γ-glutamyl group was located at C-2 of the hydroxymethyl-2,5-dihydro-furan ring on the basis of HMBC correlations of H-2/C-5 (δ C 178.9). The plane structure of compound 1 was therefore elucidated as 6-O-angeloyl oxypinnatanine.
It was noteworthy that the stereochemistry of the α-hydroxy-γ-glutamyl group of oxypinnatanine was not determined. Suppose the α-hydroxy-γ-glutamyl group originated from the γ-glutamyl group and possessed a similar stereochemistry as γ-glutamyl, conformational analysis ( Figure 3 ) indicated that H-4′ in the epimer A possesses an axial-axial coupling with H-3′a and an axialequatorial coupling with H-3′b, which is in agreement with the observed coupling constants of H-4′ (9.6 and 3.4 Hz). The α-hydroxy-γ-glutamyl group was therefore determined to be 2′S, 4′R, although the origin of the γ-glutamyl from a glutamine remains to be substantiated. The absolute configuration of C 2 of 1 was determined by comparison of its experimental ECD spectrum [10] with the calculated ECD spectrum of the model compound 1a (Figure 4 ) that possesses the chemical features of the chromophore and adjacent chiral carbons. In the 170-400 nm region, corresponding to the experimental ECD spectrum of compound 1, the simulated ECD curve of the model compound 1a showed Cotton effects in the same direction ( Figure 4) . Therefore, the absolute configuration at C 2 of 1 was assigned as S. 4 .53) to C-10 (δ C 121.7), C-11 (δ C 111.6), and C-14 (δ C 142.2), from H-11 (δ H 6.44) to C-10, and from H-14 (δ H 7.52) to C-12 (δ C 144.5) (Figure 2 ), verified the presence of a (furan-3-yl) methyl group in 2. The allantoin moiety existed in compound 2 was identified by comparing the remaining NMR data ( H 5.40;  C 173.5, 160.8, 158.5, 63.2) with those of allantoin ( H 5.24; δ C 173.6, 157.2, 156.8, and 62.5) in the literature [12] . This conclusion was further confirmed by HMBC correlations from H-5 to C-2 and C-7 as well as from H 2 -9 (δ H 4.53 and 4.48) to C-2 and C-4 ( Figure 2 ). The latter also suggested C-9 to be connected with N-3. The stereochemistry at C 5 was determined to be S by comparing its CD data [∆ (λ max ) -1.3 (236), +3.3 (206)] to those reported for (R)-(-)-1,3-dimethylallantoin [13] . Therefore, the structure of compound 2 was identified as (S)-N 3 -(furan-3-yl) methyl allantoin and was named pseudosteheterin D.
The two compounds were evaluated for their protective effects in H9c2 myocardial cells against CoCl 2 -induced injury [7] . The results showed that compound 1 was inactive in the assay, but compound 2 showed significant protective effects at 25 and 50 μmol/L, with potency comparable to that of the positive control N-acetyl cysteine (NAC) at 2 mmol/L ( Figure 5 ). 
Experimental
General: High-resolution electrospray ionization mass spectra (HRESIMS) were carried out on a Bruker Daltonics microTOF-Q II mass spectrometer (Bruker Daltoniks GmbH, Bremen, Germany) equipped with an ESI interface and hyphenated with a 1290 Infinity UHPLC system (Agilent, California, American). Optical rotations were measured on a Perkin-Elmer 341 polarimeter. UV spectra were determined in H 2 O by UV2401 with  in nm. IR spectra was recorded in cm -1 by a Perkin-TENSOR-27 spectrometer in the form of KBr tablets. NMR spectra were performed on a JEOL ECX 400
Nitrogenous
MHz NMR spectrometer, with δ in ppm, J in Hz, DSS (for D 2 O) and solvent residue (for CD 3 OD) as internal reference. For chromatography, a precoated silica gel GF 254 (Qingdao Haiyang, China), RP-18 silica gel (Merck), D101 macroporous resin (Chengyu, China) and Sephadex LH-20 (Pharmacia Biotech, Sweden) were used.
Plant Material:
The roots of Pseudostellaria heterophylla were collected from Shibing county in Guizhou province in November 2011, and identified by Professor Qing-De Long of Guizhou Medical University. A voucher specimen (accession No. BS20130901) was deposited at the Herbarium of the Department of Pharmacy, Guizhou Medical University.
Extraction and Isolation:
The dried roots of P. heterophylla (5 kg) were extracted with 70% EtOH (12 L×2 h×2) and the combined EtOH extract was concentrated in vacuum to yield a residue (465 g), which was suspended in H 2 O (0.3 g/mL) and then subjected to a D101 macroporous resin column eluted firstly with water to remove water-soluble small-molecules and sugars and then with 70% EtOH to give a glycosides-enriched extract (46 g), separation of which by MCI gel column (MeOH/H 2 O, 30% to 80%) gave three fractions Fr.1-Fr.3. Fr.2 was purified by silica gel column chromatography (CHCl 3 /MeOH, 14:1 to 8:3) and semi-preparative HPLC (15% CH 3 CN in H 2 O) to give 1 (49 mg). Fr.3 was subjected to silica gel column chromatography (CHCl 3 /MeOH, 10:1 to 8:1) and further purified on a column of Sephadex LH-20 eluted with MeOH to produce compound 2 (10 mg).
Protective effect assay:
Evaluations of the protective effects of the two compounds on the CoCl 2 -induced hypoxia of H9c2 cells followed strictly the method reported previously [7] . NAC (2000 mol/L) was used as the positive control, and the cell viability determined by the MTT method was used to evaluate the protective effects. Supplementary data: The HR-ESIMS, UV, IR, 1 H-, 13 C-NMR, DEPT 135°, HSQC, HMBC, and 1 H-1 H COSY spectra of 1 and 2 are available online.
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